The company’s board of directors approved a restructuring plan. In connection with this plan, the company expects to incur non-recurring charges in the approximate range of $55M to $65M, the majority of which will be expensed and paid in cash in 2026 and 2027. The plan is anticipated to result in approximately $120M in annualized cost savings. The company intends to reinvest a portion of the anticipated savings in targeted return-to-growth initiatives, including investments in accelerated innovation, clinical education, and sales team education focused on connected dentistry. Scavilla continued, “Our restructuring program announced today will allow us to streamline operations, improve efficiency and support a more competitive cost structure, while our decision to eliminate the dividend will enable the redeployment of capital toward share repurchases and debt reduction. These are important steps in our roadmap to drive sustained, profitable growth and deliver meaningful long-term value for our shareholders.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona reports Q4 adjusted EPS 27c, consensus 29c
- Dentsply Sirona sees FY26 adjusted EPS $1.40-$1.50, consensus $1.50
- Dentsply Sirona Expands Board with Two New Directors
- Dentsply, Burkhart Dental Supply announce expanded distribution partnership
- XRAY Earnings this Week: How Will it Perform?
